- Public Comps
- Kimberly-Clark
Kimberly-Clark Valuation Multiples
Discover Kimberly-Clark's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Henkel, Essity, Hindustan Unilever, Kao and more.
Kimberly-Clark Overview
About Kimberly-Clark
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Founded
1928
HQ

Employees
36.0K
Website
Sectors
Financials (LTM)
EV
$43B
Valuation Multiples
Start free trialKimberly-Clark Financials
Kimberly-Clark reported last 12-month revenue of $17B and EBITDA of $4B.
In the same LTM period, Kimberly-Clark generated $6B in gross profit, $4B in EBITDA, and $2B in net income.
Revenue (LTM)
Kimberly-Clark P&L
In the most recent fiscal year, Kimberly-Clark reported revenue of $16B and EBITDA of $4B.
Kimberly-Clark is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 21%, and net margin of 15%.
Financial data powered by Morningstar, Inc.
Kimberly-Clark Stock Performance
Kimberly-Clark has current market cap of $36B, and enterprise value of $43B.
Market Cap Evolution
Kimberly-Clark's stock price is $109.91.
Kimberly-Clark share price increased by 12.6% in the last 30 days, and decreased by 14.7% in the last year.
Kimberly-Clark has an EPS (earnings per share) of $7.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $43B | $36B | 0.5% | 12.6% | 13.9% | -14.7% | $7.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKimberly-Clark Valuation Multiples
Kimberly-Clark trades at 2.6x EV/Revenue multiple, and 11.9x EV/EBITDA.
EV / Revenue (LTM)
Kimberly-Clark Financial Valuation Multiples
As of June 30, 2026, Kimberly-Clark has market cap of $36B and EV of $43B.
Kimberly-Clark has a P/E ratio of 14.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kimberly-Clark Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kimberly-Clark Margins & Growth Rates
Kimberly-Clark grew revenue by 3% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, Kimberly-Clark reported gross margin of 36%, EBITDA margin of 21%, and net margin of 15%.
Kimberly-Clark Margins
Kimberly-Clark Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kimberly-Clark Operational KPIs
Kimberly-Clark's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Kimberly-Clark's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kimberly-Clark's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kimberly-Clark Competitors
Kimberly-Clark competitors include Henkel, Essity, Hindustan Unilever, Kao, Ryohin Keikaku, Clorox, Godrej Consumer Products, Kimberly-Clark de México, Lion Corp. and Colgate-Palmolive.
Most Kimberly-Clark public comparables operate across Home Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.4x | 1.4x | 8.0x | 7.9x | |||
| 1.5x | 1.5x | 8.0x | 8.3x | |||
| 7.8x | 7.8x | 31.8x | 33.0x | |||
| 1.7x | 1.6x | 11.2x | 10.8x | |||
| 2.2x | 2.1x | 16.5x | 15.1x | |||
| 2.1x | 2.3x | 9.8x | 12.1x | |||
| 7.0x | 6.8x | 33.2x | 32.7x | |||
| 2.2x | 2.2x | 8.4x | 8.6x | |||
This data is available for Pro users. Sign up to see all Kimberly-Clark competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Kimberly-Clark
Kimberly-Clark has acquired 3 companies to date.
Last acquisition by Kimberly-Clark was on November 3rd 2025. Kimberly-Clark acquired Kenvue for $49B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Kimberly-Clark
| Description | Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026. | Thinx is a New York City-based intimates company founded in 2013 that manufactures reusable leakproof underwear as alternatives to disposable menstrual products. Its product line includes period panties with absorbent gussets holding up to two tampons' worth of flow, incontinence briefs, and boyshorts made from nylon and spandex blends. Thinx sells via its e-commerce site and retailers like Target, expanding into maternity and postpartum lines. The company underwent restructuring in 2022 to focus on direct-to-consumer growth. | Softex Indonesia is a Jakarta-based manufacturer of disposable hygiene products including sanitary napkins, baby diapers, and tissue papers. Operating factories in Bekasi and Sidoarjo, it produces brands like Softex and Larissa under PT Softex Indonesia. Established in 1984 through a joint venture with Japanese partners, the company exports to Southeast Asia and serves 40% of the domestic feminine care market. |
| HQ Country | |||
| HQ City | Skillman, NJ | New York City, NY | Jakarta |
| Deal Date | 3 Nov 2025 | 24 Feb 2022 | 3 Sep 2020 |
| Valuation | $49B | $180M | $1B |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Kimberly-Clark acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kimberly-Clark
| Who are competitors of Kimberly-Clark? | Kimberly-Clark main competitors include Henkel, Essity, Hindustan Unilever, Kao, Ryohin Keikaku, Clorox, Godrej Consumer Products, Kimberly-Clark de México, Lion Corp., Colgate-Palmolive. |
See public comps similar to Kimberly-Clark
Lists including Kimberly-Clark
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.






